What is Gilead Sciences's acquisitions?

Gilead Sciences (GILD) reported acquisitions of $109M in Q1 2026.

How has Gilead Sciences's acquisitions changed year-over-year?

Gilead Sciences's acquisitions decreased by 60.1% year-over-year, from $273M to $109M.

What is the long-term trend for Gilead Sciences's acquisitions?

Over 4 years (2021 to 2025), Gilead Sciences's acquisitions has grown at a -9.3% compound annual growth rate (CAGR), from $1.58B to $1.07B.

What does acquisitions mean?

Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.

Gilead Sciences GILD Acquisitions

Acquisitions at other companies

Bristol-Myers SquibbBMY

$65M-16.7%

Merck & Co.MRK

$8.78B—

Other financials

Income statement

See full

Revenue$7.0B+4.4%

Gross profit$5.5B+7.6%

Operating income$2.6B+15.6%

Net income$2.0B+53.7%

EPS (diluted)$1.61+54.8%

Balance sheet

See full

Cash & equivalents$7.6B-3.8%

Total debt$22.2B-11.1%

Total equity$23.5B+22.7%

Total assets$56.3B-0.3%

Cash flow

See full

Operating cash flow$2.5B+44.8%

CapEx$117.0M+12.5%

Free cash flow$2.4B+46.8%

Valuation

See full

Market cap$156.86B+21.7%

Enterprise value$171.41B+15.5%

P/E17×-3.4×

P/S5.3×+0.8×

Profitability

See full

Gross margin79.4%+1.1pp

Operating margin34.9%+6.3pp

Net margin31%+10.2pp

FCF margin34.4%+0.1pp

Returns & leverage

See full

Return on equity43.2%+10.7pp

Debt / equity0.9×-0.4×

Current ratio2×+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gilead Sciences's acquisitions?: Gilead Sciences (GILD) reported acquisitions of $109M in Q1 2026.
How has Gilead Sciences's acquisitions changed year-over-year?: Gilead Sciences's acquisitions decreased by 60.1% year-over-year, from $273M to $109M.
What is the long-term trend for Gilead Sciences's acquisitions?: Over 4 years (2021 to 2025), Gilead Sciences's acquisitions has grown at a -9.3% compound annual growth rate (CAGR), from $1.58B to $1.07B.
What does acquisitions mean?: Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.